Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter
- 31 January 2011
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (9), 3785-3790
- https://doi.org/10.1073/pnas.1011920108
Abstract
Serotonin [i.e., 5-hydroxytryptamine (5-HT)]–targeted antidepressants are in wide use for the treatment of mood disorders, although many patients do not show a response or experience unpleasant side effects. Psychostimulants, such as cocaine and 3,4-methylenedioxymethamphetamine (i.e., “ecstasy”), also impact 5-HT signaling. To help dissect the contribution of 5-HT signaling to the actions of these and other agents, we developed transgenic mice in which high-affinity recognition of multiple antidepressants and cocaine is eliminated. Our animals possess a modified copy of the 5-HT transporter (i.e., SERT, slc6a4) that bears a single amino acid substitution, I172M, proximal to the 5-HT binding site. Although the M172 substitution does not impact the recognition of 5-HT, this mutation disrupts high-affinity binding of many competitive antagonists in transfected cells. Here, we demonstrate that, in M172 knock-in mice, basal SERT protein levels, 5-HT transport rates, and 5-HT levels are normal. However, SERT M172 mice display a substantial loss of sensitivity to the selective 5-HT reuptake inhibitors fluoxetine and citalopram, as well as to cocaine. Through a series of biochemical, electrophysiological, and behavioral assays, we demonstrate the unique properties of this model and establish directly that SERT is the sole protein responsible for selective 5-HT reuptake inhibitor-mediated alterations in 5-HT clearance, in 5-HT1A autoreceptor modulation of raphe neuron firing, and in behaviors used to predict the utility of antidepressants.This publication has 60 references indexed in Scilit:
- Transmembrane Domain 6 of the Human Serotonin Transporter Contributes to an Aqueously Accessible Binding Pocket for Serotonin and the Psychostimulant 3,4-Methylene Dioxymethamphetamine*Online Journal of Public Health Informatics, 2010
- Predicting new molecular targets for known drugsNature, 2009
- cGMP-dependent protein kinase Iα associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptakeMolecular Brain, 2009
- Lack of Cocaine Self-Administration in Mice Expressing a Cocaine-Insensitive Dopamine TransporterThe Journal of pharmacology and experimental therapeutics, 2009
- Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypesProceedings of the National Academy of Sciences of the United States of America, 2009
- Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient miceProceedings of the National Academy of Sciences of the United States of America, 2008
- Structural determinants of species‐selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studiesProteins, 2008
- Feeling Strained? Influence of Genetic Background on Depression-Related Behavior in Mice: A ReviewBehavior Genetics, 2006
- Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporterProceedings of the National Academy of Sciences of the United States of America, 2006
- Effect of fluoxetine on a neuronal, voltage‐dependent potassium channel (Kv1.1)British Journal of Pharmacology, 1997